Found: 5
Select item for more details and to access through your institution.
Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real‐world multicenter cohort study.
- Published in:
- Hepatology Research, 2024, v. 54, n. 7, p. 627, doi. 10.1111/hepr.14021
- By:
- Publication type:
- Article
Therapeutic Potential of Ex Vivo Expanded γδ T Cells against Osteosarcoma Cells.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 14, p. N.PAG, doi. 10.3390/cells11142164
- By:
- Publication type:
- Article
Epidermal Growth Factor Receptor: Is It a Feasible Target for the Treatment of Osteosarcoma?
- Published in:
- Cancer Research & Treatment, 2012, v. 44, n. 3, p. 202, doi. 10.4143/crt.2012.44.3.202
- By:
- Publication type:
- Article
Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 7, p. 1, doi. 10.1002/jmv.29760
- By:
- Publication type:
- Article
Development of a Bioluminescent Human Osteosarcoma Model in Humanized NSG Mice: A Pilot Study.
- Published in:
- In Vivo, 2021, v. 35, n. 4, p. 2151, doi. 10.21873/invivo.12485
- By:
- Publication type:
- Article